Benzinga - by Priya Nigam, Benzinga Staff Writer.
GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst.
Despite being a “re-accelerating high-growth, high-margin company,” the stock was trading at a discount both to its peers and its historical average, according to KeyBanc Capital Markets.
The GoodRx Holdings Club Analyst: Scott Schoenhaus upgraded the rating for GoodRx Holdings to Overweight while revising the price target to $9.
The GoodRx Holdings Club Thesis: Signs of the company’s app downloads have been “encouraging,” having accelerated in February and remaining stable in March, despite tougher comps, Schoenhaus said in the upgrade note.
Check out other analyst stock ratings.
Monthly active users (MAUs) climbed around 8.7% sequentially in February and about 2.4% in March, “which we view as a positive indication on transactions,” the analyst wrote.
According to the data from the proprietary KeyBank card holders, Gold subscribers picked up around 2% sequentially in March, Schoenhaus stated. “This is prior to the new Publix addition, where Gold membership is being rolled out across more than 1,200 locations,” he added.
GDRX Price Action: Shares of GoodRx Holdings had risen by 2.08% to $6.88 at the time of publication on Wednesday.
Read Next: Inflation Rises More Than Expected To 3.5% In March, Derails June Rate Cut Hopes (UPDATED)
Photo: Shutterstock
Latest Ratings for GDRX
| Mar 2022 | Barclays | Maintains | Overweight | |
| Mar 2022 | Morgan Stanley | Maintains | Equal-Weight | |
| Mar 2022 | Raymond James | Maintains | Outperform |
View the Latest Analyst Ratings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.